Allied Market Research
Loading...
0
2021
Over The Counter (otc) Test Market

Over The Counter (OTC) Test Market by Product Type (Glucose Monitoring Test, Pregnancy & Fertility test, Coagulation Monitoring Test, Urinalysis Test, Cholesterol Test, and Other Test), Technology (Lateral Flow Assays, Immunoassays, and Dipsticks), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021––2030

A10465
Pages: 353
Oct 2021 | 1839 Views
   
Author(s) : Linu Dash , Onkar Sumant
Tables: 176
Charts: 54
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Over The Counter (otc) Test Market

Request Now !

The global over-the-counter (OTC) test market size was valued at $13,498.50 million in 2020, and is estimated to reach $39,937.90 million by 2030, growing at a CAGR of 11.7% from 2021 to 2030. Over-the-counter (OTC) testing medical devices are directly available to the consumer and they do not require a prescription for sale. They can be used outside healthcare facilities, such as home, school, office, and communities. The over-the-counter testing products are adequately labelled with proper instruction such that the consumer is able to understand its usage, without any help from a physician. According to Food and Drug Administration (FDA), the safety margin of over-the-counter medical device and testing products are such that the benefits of having an available over-the-counter device outweighs the risks. 

The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global over-the-counter test market. The COVID-19 pandemic has stressed the healthcare systems in the world and increased the need for the development of advanced at-home over-the-counter testing product. Increase in the spread of COVID-19 infection surged the demand for over-the-counter COVID-19 test kit.

Growth of the global over-the-counter test market is majorly driven by increase in prevalence of chronic and infectious disease such as heart disease, diabetics, respiratory infection; rise in demand for point-of-care, over-the-counter diagnostic test; increase in funding from private & government organizations for development of pharmaceutical and biotechnology industry; and advancements in technologies for over-the-counter test products. According to the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that approximately 1.7 million infections and 99,000 associated deaths occur every year in American hospitals. 

Over-the-Counter-Test-Market

Get more information on this report : Request Sample Pages

Furthermore, surge in demand for point-of-care testing is anticipated to fuel the growth of the over-the-counter (OTC) test market. For instance, in April 2021, Food and Drug Administrative (FDA), announced the approval of over-the-counter (over-the-counter) and point-of-care (POC) testing for COVID-19. The combination of POC and over-the-counter test products such as Abbott BinaxNOW COVID-19 Ag self-test, Quidel Quicdel QuickVue at-home over-the-counter COVID-19 test and BD veritor system are used for detecting and screening of respiratory infection in school, workplaces, and communities. In addition, rise in geriatric population fuels the OTC market growth, owing to the fact that aged individuals are susceptible to chronic and infectious diseases. According to the U.S. Food and Drug Administration (FDA), in 2020, it was reported that around 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year.

Moreover, in 2018, Roche, a multinational healthcare company, announced the launch of CoaguCheck vantus system, which is a self-test device designed with advanced feature for monitoring blood coagulation, specially for patient on warfarin therapy. Thus, technological advancements in development of over-the-counter test and rise in awareness among individual regarding early diagnosis propel the growth of the OTC test market. However, high cost associated with over-the-counter test products is expected to restrict the over-the-counter market growth during the forecast period.

Over-the-counter Test Market Segmentation

The over-the-counter test market is segmented into product type, technology, distribution channel, and region. By product type, the market is categorized into glucose monitoring test, pregnancy & fertility test, coagulation monitoring test, urinalysis test, cholesterol test, and other test. The glucose monitoring test segment is further classified into blood glucose meters, testing strips, and lancets. The pregnancy & fertility test segment is further divided into pregnancy test and fertility test.

Depending on technology, it is categorized into lateral flow assays, immunoassays, and dipsticks. By distribution channel, the OTC test market is fragmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Over The Counter (OTC) Test Market
By Product

Your browser does not support the canvas element.

Glucose Monitoring Tests segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment Review

Depending on product type, the glucose monitoring test segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in prevalence of diabetics, and surge in demand for glucometer. However, the pregnancy & fertility test segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of infertility disorder, increasing birth rate, availability of the fertility testing device, and advancement in technology to develop pregnancy and fertility test product.

Over The Counter (OTC) Test Market
By Technology

Your browser does not support the canvas element.

Lateral Flow Assays segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of technology, the lateral flow assays segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to rise in prevalence of infectious diseases, increasing number of key players for manufacturing of lateral flow assay kits and surge in demand for home based lateral flow assay devices However, the immunoassays segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of chronic disease, advancement in technology for development of advanced immunoassays, and increase in demand for immunoassay for detection of antibody.

By distribution channel, the hospital pharmacies segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to rise in prevalence of diabetics, surge in demand for self-monitoring devices and initiative taken by government for advancement of hospital pharmacy. However, the online pharmacies segment is expected to witness considerable growth during the forecast period, due to advancement in technology in the healthcare sector and a rise in demand for remote service.

Over The Counter (OTC) Test Market
By Distribution Channel

Your browser does not support the canvas element.

Hospital Pharmacy segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America garnered the major share in the over-the-counter test market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of chronic disease, increase in number of approval for over-the-counter test product, the presence of key players, and development in technology for healthcare in the region. However, Asia-Pacific is expected to register the highest CAGR of 13.2% from 2021 to 2030, owing to increase in prevalence of chronic and infectious disease, rise in number of geriatric population, growth in health care expenditures, and rise in adoption of over-the-counter test product.

The key players operating in the global over-the-counter test market include Abbott Laboratories, Abingdon Health PLC, AccuBioTech Co., Ltd., Acon Laboratories Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Clip Health, Dario Health Corp, Ellume Health Ltd, Eurofins Scientific Group, F. Hoffmann-La Roche AG, Lia Diagnostics Inc, Lifescan IP Holdings, LLC, Lucira Health, Inc, Now Diagnostics Inc, Orasure Technologies Inc, PHC Holdings Corporation, Quidel Corporation, SD Biosensor Inc., and Sinocare Inc.

Over The Counter (OTC) Test Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the over-the-counter test market, and the current trends & future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing OTC test market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the over-the-counter test market.

Key Market Segments

By Product Type

  • Glucose Monitoring Test
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
  • Pregnancy & Fertility Test
    • Pregnancy Test
    • Fertility Test
  • Coagulation Monitoring Test
  • Urinalysis Test
  • Cholesterol Test
  • Other Test

By Technology

  • Lateral Flow Assays
  • Immunoassays
  • Dipsticks

By Distribution Channel

  • Hospital Pharmacy 
  • Retail Pharmacy
  • Online pharmacy

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players 

  • Abbott Laboratories
  • Abingdon Health PLC 
  • AccuBioTech Co., Ltd. 
  • Acon Laboratories Inc. 
  • B. Braun Melsungen AG 
  • Becton Dickinson and Company
  • Clip Health 
  • Dario Health Corp
  • Ellume Health Ltd
  • Eurofins Scientific Group
  • F. Hoffmann-La Roche AG 
  • Lia Diagnostics Inc
  • Lifescan IP Holdings, LLC
  • Lucira Health, Inc
  • Now Diagnostics Inc
  • Orasure Technologies Inc
  • PHC Holdings Corporation 
  • Quidel Corporation 
  • SD Biosensor Inc.
  • Sinocare Inc.
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of chronic and infectious disease
3.5.1.2.Increase in number of approval for the over-the-counter tests product
3.5.1.3.Advancement in technology to develop over-the-counter tests product
3.5.1.4.Surge in demand for early diagnosis of disease

3.5.2.Restraints

3.5.2.1.High cost of diagnostic instruments
3.5.2.2.Lack of awareness about technology among individual

3.5.3.Opportunities

3.5.3.1.Increase in healthcare expenditure worldwide
3.5.3.2.Development of advanced at-home testing devices by key players

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the over-the-counter tests market

CHAPTER 4:OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE

4.1.overview

4.1.1.Market size and forecast
4.1.2.Market Volume and forecast

4.2.Glucose Monitoring Tests

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Glucose Monitoring Tests, by Type

4.2.2.1.Market size and forecast
4.2.2.2.Market volume and forecast
4.2.2.3.Blood Glucose meters

4.2.2.3.1.Market size and forecast

4.2.2.4.Testing strips

4.2.2.4.1.Market size and forecast

4.2.2.5.Lancets

4.2.2.5.1.Market size and forecast

4.2.3.Market size and forecast, by region
4.2.4.Market volume and forecast, by region
4.2.5.Market analysis, by country

4.3.Pregnancy & Fertility Tests

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Pregnancy and Fertility Tests, by Type

4.3.2.1.Market size and forecast
4.3.2.2.Market volume and forecast
4.3.2.3.Pregnancy Test

4.3.2.3.1.Market size and forecast

4.3.2.4.Fertility Test

4.3.2.4.1.Market size and forecast

4.3.3.Market size and forecast, by region
4.3.4.Market volume and forecast, by region
4.3.5.Market analysis, by country

4.4.Coagulation Monitoring Tests

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market volume and forecast, by region
4.4.4.Market analysis, by country

4.5.Urinalysis Tests

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market volume and forecast, by region
4.5.4.Market analysis, by country

4.6.Cholesterol Tests

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market volume and forecast, by region
4.6.4.Market analysis, by country

4.7.Other Tests

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market volume and forecast, by region
4.7.4.Market analysis, by country

CHAPTER 5:OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY

5.1.overview

5.1.1.Market size and forecast

5.2.Lateral Flow Assays

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Immunoassays

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Dipsticks

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

CHAPTER 6:OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL

6.1.overview

6.1.1.Market size and forecast

6.2.Hospital Pharmacies

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Retail Pharmacies

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Online Pharmacies

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

CHAPTER 7:OVER-THE-COUNTER TESTS  MARKET, BY REGION

7.1.overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America  over-the-counter tests  market, by product type
7.2.3.North America  over-the-counter tests  market, by technology
7.2.4.North America  over-the-counter tests  market, by distribution channel
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. over-the-counter tests  market, by product type
7.2.5.1.2.U.S. over-the-counter tests market, by technology
7.2.5.1.3.U.S. over-the-counter tests market, by distribution channel

7.2.5.2.Canada

7.2.5.2.1.Canada over-the-counter tests  market, by product type
7.2.5.2.2.Canada over-the-counter tests market, by technology
7.2.5.2.3.Canada over-the-counter tests market, by distribution channel

7.2.5.3.Mexico

7.2.5.3.1.Mexico over-the-counter tests  market, by product type
7.2.5.3.2.Mexico over-the-counter tests market, by technology
7.2.5.3.3.Mexico over-the-counter tests market, by distribution channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe over-the-counter tests  market, by product type
7.3.3.Europe over-the-counter tests  market, by technology
7.3.4.Europe over-the-counter tests market, by distribution channel
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany over-the-counter tests  market, by product type
7.3.5.1.2.Germany over-the-counter tests market, by technology
7.3.5.1.3.Germany over-the-counter tests market, by distribution channel

7.3.5.2.France

7.3.5.2.1.France over-the-counter tests  market, by product type
7.3.5.2.2.France over-the-counter tests market, by technology
7.3.5.2.3.France over-the-counter tests market, by distribution channel

7.3.5.3.UK

7.3.5.3.1.UK over-the-counter tests  market, by product type
7.3.5.3.2.UK over-the-counter tests market, by technology
7.3.5.3.3.UK over-the-counter tests market, by distribution channel

7.3.5.4.Italy

7.3.5.4.1.Italy over-the-counter tests  market, by product type
7.3.5.4.2.Italy over-the-counter tests market, by technology
7.3.5.4.3.Italy over-the-counter tests market, by distribution channel

7.3.5.5.Spain

7.3.5.5.1.Spain over-the-counter tests  market, by product type
7.3.5.5.2.Spain over-the-counter tests market, by technology
7.3.5.5.3.Spain over-the-counter tests market, by distribution channel

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe over-the-counter tests  market, by product type
7.3.5.6.2.Rest of Europe over-the-counter tests market, by technology
7.3.5.6.3.Rest of Europe over-the-counter tests market, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific over-the-counter tests  market, by product type
7.4.3.Asia-Pacific over-the-counter tests  market, by technology
7.4.4.Asia-Pacific over-the-counter tests  market, by distribution channel
7.4.5.Market size and forecast, by country

7.4.5.1.China

7.4.5.1.1.China over-the-counter tests  market, by product type
7.4.5.1.2.China over-the-counter tests market, by technology
7.4.5.1.3.China over-the-counter tests market, by distribution channel

7.4.5.2.Japan

7.4.5.2.1.Japan over-the-counter tests  market, by product type
7.4.5.2.2.Japan over-the-counter tests market, by technology
7.4.5.2.3.Japan over-the-counter tests market, by distribution channel

7.4.5.3.India

7.4.5.3.1.India over-the-counter tests  market, by product type
7.4.5.3.2.India over-the-counter tests market, by technology
7.4.5.3.3.India over-the-counter tests market, by distribution channel

7.4.5.4.Australia

7.4.5.4.1.Australia over-the-counter tests  market, by product type
7.4.5.4.2.Australia over-the-counter tests market, by technology
7.4.5.4.3.Australia over-the-counter tests market, by distribution channel

7.4.5.5.South Korea

7.4.5.5.1.South Korea over-the-counter tests  market, by product type
7.4.5.5.2.South Korea over-the-counter tests market, by technology
7.4.5.5.3.South Korea over-the-counter tests market, by distribution channel

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Rest of Asia-Pacific over-the-counter tests  market, by product type
7.4.5.6.2.Rest of Asia-Pacific over-the-counter tests market, by technology
7.4.5.6.3.Rest of Asia-Pacific over-the-counter tests market, by distribution channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA over-the-counter tests  market, by product type
7.5.3.LAMEA over-the-counter tests  market, by technology
7.5.4.LAMEA over-the-counter tests  market, by distribution channel
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil over-the-counter tests  market, by product type
7.5.5.1.2.Brazil over-the-counter tests market, by technology
7.5.5.1.3.Brazil over-the-counter tests market, by distribution channel

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia over-the-counter tests  market, by product type
7.5.5.2.2.Saudi Arabia over-the-counter tests market, by technology
7.5.5.2.3.Saudi Arabia over-the-counter tests market, by distribution channel

7.5.5.3.South Africa

7.5.5.3.1.South Africa over-the-counter tests  market, by product type
7.5.5.3.2.South Africa over-the-counter tests market, by technology
7.5.5.3.3.South Africa over-the-counter tests market, by distribution channel

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA over-the-counter tests  market, by product type
7.5.5.4.2.Rest of LAMEA over-the-counter tests market, by technology
7.5.5.4.3.Rest of LAMEA over-the-counter tests market, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.Abbott Laboratories

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.Abingdon Health PLC

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.AccuBioTech Co., Ltd

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments

8.4.Acon Laboratories, INC.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments

8.5.B. Braun Melsungen AG

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.Becton, Dickinson and Company

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.Clip Health

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Key strategic moves and developments

8.8.Dario Health Corp.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio

8.8.5.Business performance

8.9.Ellume Health Ltd.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments

8.10.Eurofins Scientific Group

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

8.11.F. Hoffmann-La Roche AG (Roche Diagnostics)
8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Business performance
8.11.6.Key strategic moves and developments

8.12.Lia Diagnostics Inc.

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio

8.13.LifeScan IP Holdings, LLC

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Key strategic moves and developments

8.14.Lucira Health, Inc.

8.14.1.Company overview
8.14.2.Company snapshot
8.14.3.Operating business segments
8.14.4.Product portfolio
8.14.5.Business performance
8.14.6.Key strategic moves and developments

8.15.Now Diagnostics Inc.

8.15.1.Company overview
8.15.2.Company snapshot
8.15.3.Operating business segments
8.15.4.Product portfolio
8.15.5.Key strategic moves and developments

8.16.Orasure Technologies Inc.

8.16.1.Company overview
8.16.2.Company snapshot
8.16.3.Operating business segments
8.16.4.Product portfolio
8.16.5.Business performance
8.16.6.Key strategic moves and developments

8.17.PHC Holdings Corporation

8.17.1.Company overview
8.17.2.Company snapshot
8.17.3.Operating business segments
8.17.4.Product portfolio
8.17.5.Key strategic moves and developments

8.18.Quidel Corporation

8.18.1.Company overview
8.18.2.Company snapshot
8.18.3.Operating business segments
8.18.4.Product portfolio
8.18.5.Business performance
8.18.6.Key strategic moves and developments

8.19.SD Biosensor, Inc.

8.19.1.Company overview
8.19.2.Company snapshot
8.19.3.Operating business segments
8.19.4.Product portfolio
8.19.5.Business performance
8.19.6.Key strategic moves and developments

8.20.Sinocare Inc.

8.20.1.Company overview
8.20.2.Company snapshot
8.20.3.Operating business segments
8.20.4.Product portfolio

LIST OF TABLES

TABLE 01.GLOBAL OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 02.GLOBAL OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020–2030 (UNITS)
TABLE 03.OVER-THE-COUNTER TEST MARKET FOR GLUCOSE MONITORING TESTS BY TYPE, 2020-2030 ($MILLION)
TABLE 04.OVER-THE-COUNTER TEST MARKET FOR GLUCOSE MONITORING TESTS BY TYPE, 2020-2030 (UNITS)
TABLE 05.OVER-THE-COUNTER TESTS MARKET FOR  GLUCOSE MONITORING TESTS, BY REGION, 2020–2030 ($MILLION)
TABLE 06.OVER-THE-COUNTER TESTS MARKET FOR  GLUCOSE MONITORING TESTS, BY REGION, 2020–2030 (UNITS)
TABLE 07.OVER-THE-COUNTER TEST MARKET FOR PREGNANCY & FERTILITY TESTS BY TYPE, 2020-2030 ($MILLION)
TABLE 08.OVER-THE-COUNTER TEST MARKET FOR PREGNANCY & FERTILITY TESTS BY TYPE, 2020-2030 (UNITS)
TABLE 09.OVER-THE-COUNTER TEST MARKET FOR  PREGNANCY AND FERTILITY TESTS, BY REGION, 2020–2030 ($MILLION)
TABLE 10.OVER-THE-COUNTER TEST MARKET FOR  PREGNANCY AND FERTILITY TESTS, BY REGION, 2020–2030 (UNITS)
TABLE 11.OVER-THE-COUNTER TESTS MARKET FOR COAGULATION MONITORING TESTS, BY REGION, 2020–2030 ($MILLION)
TABLE 12.OVER-THE-COUNTER TEST MARKET FOR  COAGULATION MONITORING TESTS, BY REGION, 2020–2030 (UNITS)
TABLE 13.OVER-THE-COUNTER TESTS MARKET FOR URINALYSIS TESTS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.OVER-THE-COUNTER TEST MARKET FOR  URINALYSIS TESTS, BY REGION, 2020–2030 (UNITS)
TABLE 15.OVER-THE-COUNTER TESTS MARKET FOR CHOLESTEROL TESTS, BY REGION, 2020–2030 ($MILLION)
TABLE 16.OVER-THE-COUNTER TEST MARKET FOR  CHOLESTEROL TESTS, BY REGION, 2020–2030 (UNITS)
TABLE 17.OVER-THE-COUNTER TESTS MARKET FOR OTHER TESTS, BY REGION, 2020–2030 ($MILLION)
TABLE 18.OVER-THE-COUNTER TEST MARKET FOR  OTHERS TEST, BY REGION, 2020–2030 (UNITS)
TABLE 19.GLOBAL OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 20.OVER-THE-COUNTER TESTS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2020–2030 ($MILLION)
TABLE 21.OVER-THE-COUNTER TESTS MARKET FOR IMMUNOASSAYS, BY REGION, 2020–2030 ($MILLION)
TABLE 22.OVER-THE-COUNTER TESTS MARKET FOR DIPSTICKS, BY REGION, 2020–2030 ($MILLION)
TABLE 23.GLOBAL OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 24.OVER-THE-COUNTER TESTS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020–2030 ($MILLION)
TABLE 25.OVER-THE-COUNTER TESTS MARKET FOR RETAIL PHARMACIES, BY REGION, 2020–2030 ($MILLION)
TABLE 26.OVER-THE-COUNTER TESTS MARKET FOR ONLINE PHARMACIES, BY REGION, 2020–2030 ($MILLION)
TABLE 27.OVER-THE-COUNTER TESTS  MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 28.NORTH AMERICA  OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 29.NORTH AMERICA  OVER-THE-COUNTER TESTS  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 30.NORTH AMERICA  OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 31.NORTH AMERICA  OVER-THE-COUNTER TESTS  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.U.S. OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 33.U.S. OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 34.U.S. OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 35.CANADA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 36.CANADA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 37.CANADA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 38.MEXICO OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 39.MEXICO OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 40.MEXICO OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 41.EUROPE OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 42.EUROPE OVER-THE-COUNTER TESTS  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 43.EUROPE OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 44.EUROPE OVER-THE-COUNTER TESTS  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 45.GERMANY OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 46.GERMANY OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 47.GERMANY OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 48.FRANCE OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 49.FRANCE OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 50.FRANCE OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 51.UK OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 52.UK OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 53.UK OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 54.ITALY OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 55.ITALY OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 56.ITALY OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 57.SPAIN OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 58.SPAIN OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 59.SPAIN OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 60.REST OF EUROPE OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 61.REST OF EUROPE OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 62.REST OF EUROPE OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 63.ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 64.ASIA-PACIFIC OVER-THE-COUNTER TESTS  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 65.ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 66.ASIA-PACIFIC  OVER-THE-COUNTER TESTS  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 67.CHINA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 68.CHINA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 69.CHINA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 70.JAPAN OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 71.JAPAN OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 72.JAPAN OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 73.INDIA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 74.INDIA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 75.INDIA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 76.AUSTRALIA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 77.AUSTRALIA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 78.AUSTRALIA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 79.SOUTH KOREA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 80.SOUTH KOREA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 81.SOUTH KOREA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 82.REST OF ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 83.REST OF ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 84.REST OF ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 85.LAMEA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 86.LAMEA OVER-THE-COUNTER TESTS  MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 87.LAMEA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 88.LAMEA  OVER-THE-COUNTER TESTS  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 89.BRAZIL OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 90.BRAZIL OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 91.BRAZIL OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 92.SAUDI ARABIA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 93.SAUDI ARABIA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 94.SAUDI ARABIA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 95.SOUTH AFRICA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 96.SOUTH AFRICA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 97.SOUTH AFRICA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 98.REST OF LAMEA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 99.REST OF LAMEA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 100.REST OF LAMEA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 101.ABBOTT: COMPANY SNAPSHOT
TABLE 102.ABBOTT: OPERATING SEGMENTS
TABLE 103.ABBOTT: PRODUCT PORTFOLIO
TABLE 104.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105.ABINGDON HEALTH: COMPANY SNAPSHOT
TABLE 106.ABINGDON HEALTH: OPERATING SEGMENTS
TABLE 107.ABINGDON HEALTH: PRODUCT PORTFOLIO
TABLE 108.ABINGDON HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109.ACCUBIOTECH: COMPANY SNAPSHOT
TABLE 110.ACCUBIOTECH: OPERATING SEGMENTS
TABLE 111.ACCUBIOTECH: PRODUCT PORTFOLIO
TABLE 112.ACCUBIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113.ACON LABORATORIES: COMPANY SNAPSHOT
TABLE 114.ACON LABORATORIES: OPERATING SEGMENTS
TABLE 115.ACON LABORATORIES: PRODUCT PORTFOLIO
TABLE 116.ACON LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117.B. BRAUN: COMPANY SNAPSHOT
TABLE 118.B. BRAUN: OERATING SEGMENT
TABLE 119.B. BRAUN: PRODUCT PORTFOLIO
TABLE 120.BD: COMPANY SNAPSHOT
TABLE 121.BD: OPERATING SEGMENTS
TABLE 122.BD: PRODUCT PORTFOLIO
TABLE 123.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.CLIP HEALTH: COMPANY SNAPSHOT
TABLE 125.CLIP HEALTH: OERATING SEGMENT
TABLE 126.CLIP HEALTH: PRODUCT PORTFOLIO
TABLE 127.CLIP HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128.DARIO HEALTH: COMPANY SNAPSHOT
TABLE 129.DARIO HEALTH: OERATING SEGMENT
TABLE 130.DARIO HEALTH: PRODUCT PORTFOLIO
TABLE 131.ELLUME HEALTH: COMPANY SNAPSHOT
TABLE 132.ELLUME HEALTH: OERATING SEGMENT
TABLE 133.ELLUME HEALTH: PRODUCT PORTFOLIO
TABLE 134.ELLUME HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135.EUROFINS: COMPANY SNAPSHOT
TABLE 136.EUROFINS: OPERATING SEGMENTS
TABLE 137.EUROFINS: PRODUCT PORTFOLIO
TABLE 138.EUROFINS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 139.ROCHE: COMPANY SNAPSHOT
TABLE 140.ROCHE: OPERATING SEGMENTS
TABLE 141.ROCHE: PRODUCT PORTFOLIO
TABLE 142.ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143.LIA DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 144.LIA DIAGNOSTICS: OPERATING SEGMENTS
TABLE 145.LIA DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 146.LIFESCAN IP: COMPANY SNAPSHOT
TABLE 147.LIFESCAN IP: OERATING SEGMENT
TABLE 148.LIFESCAN IP: PRODUCT PORTFOLIO
TABLE 149.LIFESCAN IP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 150.LUCIRA HEALTH: COMPANY SNAPSHOT
TABLE 151.LUCIRA HEALTH: OPERATING SEGMENTS
TABLE 152.LUCIRA HEALTH: PRODUCT PORTFOLIO
TABLE 153.LUCIRA HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154.NOW DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 155.NOW DIAGNOSTICS: OPERATING SEGMENTS
TABLE 156.NOW DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 157.NOW DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 158.ORASURE TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 159.ORASURE TECHNOLOGIES: OERATING SEGMENT
TABLE 160.ORASURE TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 161.ORASURE TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 162.PHC HOLDINGS: COMPANY SNAPSHOT
TABLE 163.PHC HOLDINGS: OPERATING SEGMENTS
TABLE 164.PHC HOLDINGS: PRODUCT PORTFOLIO
TABLE 165.PHC HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 166.QUIDEL: COMPANY SNAPSHOT
TABLE 167.QUIDEL: OPERATING SEGMENTS
TABLE 168.QUIDEL: PRODUCT PORTFOLIO
TABLE 169.QUIDEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 170.SD BIOSENSOR: COMPANY SNAPSHOT
TABLE 171.SD BIOSENSOR: OPERATING SEGMENTS
TABLE 172.SD BIOSENSOR: PRODUCT PORTFOLIO
TABLE 173.SD BIOSENSOR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 174.SINOCARE: COMPANY SNAPSHOT
TABLE 175.SINOCARE: OERATING SEGMENT
TABLE 176.SINOCARE: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.OVER-THE-COUNTER TESTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.OVER-THE-COUNTER TEST MARKET FOR BLOOD GLUCOSE METERS, 2020-2030 ($MILLION)
FIGURE 14.OVER-THE-COUNTER TEST MARKET FOR TESTING STRIPS, 2020-2030 ($MILLION)
FIGURE 15.OVER-THE-COUNTER TEST MARKET FOR LANCETS, 2020-2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR GLUCOSE MONITORING TESTS, BY COUNTRY, 2020–2030 (%)
FIGURE 17.OVER-THE-COUNTER TESTS MARKET FOR PREGNANCY TEST, 2020-2030 ($MILLION)
FIGURE 18.OVER-THE-COUNTER TESTS MARKET FOR FERTILITY TEST, 2020-2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY,  2020–2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR COAGULATION MONITORING TESTS, BY COUNTRY, 2020–2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR URINALYSIS TESTS, BY COUNTRY, 2020–2030 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR CHOLESTEROL TESTS, BY COUNTRY, 2020–2030 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR OTHER TESTS, BY COUNTRY, 2020–2030 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2020–2030 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2020–2030 (%)
FIGURE 26.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2020–2030 (%)
FIGURE 27.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2020–2030 (%)
FIGURE 28.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020–2030 (%)
FIGURE 29.COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2020–2030 (%)
FIGURE 30.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.ABINGDON HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 34.ABINGDON HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.ABINGDON HEALTH: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36.B. BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.B. BRAUN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.B. BRAUN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 40.BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41.BD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 42.DARIO HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 43.EUROFINS: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.EUROFINS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 45.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.ROCHE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 48.LUCIRA HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 49.ORASURE TECHNOLOGIES: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.ORASURE TECHNOLOGIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 51.ORASURE TECHNOLOGIES: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 52.QUIDEL: NET SALES, 2018–2020 ($MILLION)
FIGURE 53.QUIDEL: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54.SD BIOSENSOR: NET SALES, 2018–2020 ($MILLION)


 
 

Growth of the over-the-counter test market is attributed to factors such as technological advancements in the healthcare sector; rise in prevalence of chronic and infectious diseases such as diabetic, cardiovascular disease, HIV, & COVID-19; increase development of healthcare sector for manufacturing advanced over-the-counter test products; and rise in awareness about early diagnosis. The over-the-counter test market gains interest of pharmaceutical and biotechnology companies, owing to surge in demand for point-of-care over-the-counter diagnostic testing. This leads to increase in adoption of over-the-counter testing for detection and monitoring of chronic diseases. Moreover, advancement in technology, such as lateral flow assay, immunoassay, and dipstick, have gained high traction in the market in recent years, as these having its application in over-the-counter test products.

North America is expected to witness the highest growth, in terms of revenue, owing to rise in prevalence of chronic disease, increase in number of approval for over-the-counter test product, the presence of key players, and development in technology for healthcare in the region.

Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in prevalence of chronic and infectious disease, rise in number of geriatric population, growth in health care expenditures, and rise in adoption of over-the-counter test product.

However, high cost associated with over-the-counter testing products is anticipated to restrain the market growth during the forecast period.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Over the Counter Test market is $13,498.5 million in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of Over the Counter Test market in 2021 was $14,741.71 million

A. The base year for the report is 2020.

A. Yes, Over the Counter Test companies are profiled in the report

A. The top companies that hold the market share in Over the Counter Test market are Abbott Laboratories, Abingdon Health PLC, AccuBioTech Co., Ltd., Acon Laboratories Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Clip Health, Dario Health Corp, Ellume Health Ltd, Eurofins Scientific Group, F. Hoffmann-La Roche AG, Lia Diagnostics Inc, Lifescan IP Holdings, LLC, Lucira Health, Inc, Now Diagnostics Inc, Orasure Technologies Inc, PHC Holdings Corporation, Quidel Corporation, SD Biosensor Inc., and Sinocare Inc

A. Asia-Pacific is expected to register the highest CAGR of 13.2% from 2021 to 2030, owing to increase in prevalence of chronic and infectious disease, rise in number of geriatric population, growth in health care expenditures, and rise in adoption of over the counter tests product

A. The key trends in the Over the Counter Test market are by increase in prevalence of chronic and infectious disease such as heart disease, diabetics, respiratory infection; rise in demand for point-of-care over-the-counter diagnostic test; increase in funding from private & government organizations for development of pharmaceutical and biotechnology industry; and advancements in technologies for over the counter tests products.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Over The Counter (otc) Test Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers